- Home
- SPHL vs BFRG Comparison
SPHL vs BFRG Comparison
Compare SPHL & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- BFRG
- Stock Information
- Founded
- SPHL 2002
- BFRG 2017
- Country
- SPHL Singapore
- BFRG United States
- Employees
- SPHL N/A
- BFRG N/A
- Industry
- SPHL Homebuilding
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- SPHL Consumer Discretionary
- BFRG Technology
- Exchange
- SPHL Nasdaq
- BFRG Nasdaq
- Market Cap
- SPHL 27.5M
- BFRG 31.8M
- IPO Year
- SPHL 2024
- BFRG 2023
- Fundamental
- Price
- SPHL $2.60
- BFRG $2.85
- Analyst Decision
- SPHL
- BFRG
- Analyst Count
- SPHL 0
- BFRG 0
- Target Price
- SPHL N/A
- BFRG N/A
- AVG Volume (30 Days)
- SPHL 410.6K
- BFRG 1.9M
- Earning Date
- SPHL 02-21-2025
- BFRG 03-28-2025
- Dividend Yield
- SPHL N/A
- BFRG N/A
- EPS Growth
- SPHL 413.11
- BFRG N/A
- EPS
- SPHL 0.09
- BFRG N/A
- Revenue
- SPHL $11,020,429.00
- BFRG N/A
- Revenue This Year
- SPHL N/A
- BFRG N/A
- Revenue Next Year
- SPHL N/A
- BFRG N/A
- P/E Ratio
- SPHL $30.41
- BFRG N/A
- Revenue Growth
- SPHL 112.84
- BFRG 550.00
- 52 Week Low
- SPHL $1.42
- BFRG $1.43
- 52 Week High
- SPHL $7.16
- BFRG $5.52
- Technical
- Relative Strength Index (RSI)
- SPHL N/A
- BFRG 50.42
- Support Level
- SPHL N/A
- BFRG $2.81
- Resistance Level
- SPHL N/A
- BFRG $4.84
- Average True Range (ATR)
- SPHL 0.00
- BFRG 0.64
- MACD
- SPHL 0.00
- BFRG 0.00
- Stochastic Oscillator
- SPHL 0.00
- BFRG 24.05
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.